<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001320982</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001723128</issuerCik>
      <issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-38485</secFileNumber>
      <issuerAddress>
        <com:street1>400 CROSSING BLVD</com:street1>
        <com:city>BRIDGEWATER</com:city>
        <com:stateOrCountry>NJ</com:stateOrCountry>
        <com:zipCode>08807</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(908) 947-3120</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Konidaris Tasos</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>100000</noOfUnitsSold>
      <aggregateMarketValue>884000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>309966341</noOfUnitsOutstanding>
      <approxSaleDate>03/05/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/12/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>87719</amountOfSecuritiesAcquired>
      <paymentDate>03/12/2021</paymentDate>
      <natureOfPayment>Services Rendered</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/01/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>12281</amountOfSecuritiesAcquired>
      <paymentDate>03/01/2022</paymentDate>
      <natureOfPayment>Services Rendered</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>03/05/2025</noticeDate>
      <signature>Anastasios Konidaris</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3274}]
144
0001320982
XXXXXXXX
LIVE
0001723128
Amneal Pharmaceuticals, Inc.
001-38485
400 CROSSING BLVD
BRIDGEWATER
NJ
08807
(908) 947-3120
Konidaris Tasos
Officer
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
100000
884000.00
309966341
03/05/2025
NASDAQ
Common
03/12/2021
Equity Compensation
Issuer
N
87719
03/12/2021
Services Rendered
Common
03/01/2022
Equity Compensation
Issuer
N
12281
03/01/2022
Services Rendered
Y
03/05/2025
Anastasios Konidaris